Clarigent

Clarigent Health launches an app-based listening tool to support mental health risk reduction

Clarigent Health, a mental health technology company, today announced the launch of Clairity, an app-based listening tool designed to provide clinical decision support to mental health professionals. Clairity analyzes speech with artificial intelligence (AI) trained to identify patients at risk of suicide. For mental health professionals, whose observations are informed by education, practice, and experience, Clairity is designed to provide an additional objective metric to help identify potential risks.

Clairity AI identifies vocal biomarkers – noninvasive, objective indicators of mental health states. The vocal biomarkers are tracked over time alongside patient-reported symptoms and clinical impressions. Voice data and clinical impressions are captured by the Clairity app. Standardized patient assessments can be captured in the app or imported securely if they have been captured elsewhere. Clairity returns personalized session summaries, patient-specific treatment progress, and aggregated data to help assess risk across a patient

Read More

Clarigent Health launches Clairity to support mental health risk reduction

IMAGE

IMAGE: Example of Clairity in use.
view more 

Credit: Clarigent Health

MASON, OH – October 1, 2020 – Clarigent Health, a mental health technology company, today announced the launch of Clairity, an app-based listening tool designed to provide clinical decision support to mental health professionals. Clairity analyzes speech with artificial intelligence (AI) trained to identify patients at risk of suicide. For mental health professionals, whose observations are informed by education, practice, and experience, Clairity is designed to provide an additional objective metric to help identify potential risks.

Clairity AI identifies vocal biomarkers – noninvasive, objective indicators of mental health states. The vocal biomarkers are tracked over time alongside patient-reported symptoms and clinical impressions. Voice data and clinical impressions are captured by the Clairity app. Standardized patient assessments can be captured in the app or imported securely if they have been captured elsewhere. Clairity returns personalized session summaries, patient-specific treatment progress,

Read More

Clarigent Health Launches Clairity, Tracking Vocal Biomarkers to Support Mental Health Risk Reduction

Clairity supports clinical decisions and care with AI analysis of patient speech, treatment progress trends, and risk radar across patient groups

Clarigent Health, a mental health technology company, today announced the launch of Clairity, an app-based listening tool designed to provide clinical decision support to mental health professionals. Clairity analyzes speech with artificial intelligence (AI) trained to identify patients at risk of suicide. For mental health professionals, whose observations are informed by education, practice, and experience, Clairity is designed to provide an additional objective metric to help identify potential risks.

Clairity AI identifies vocal biomarkers – noninvasive, objective indicators of mental health states. The vocal biomarkers are tracked over time alongside patient-reported symptoms and clinical impressions. Voice data and clinical impressions are captured by the Clairity app. Standardized patient assessments can be captured in the app or imported securely if they have been captured elsewhere. Clairity returns personalized session summaries,

Read More